Is Catalyst Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-28 11:41:13As of 24 October 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD is mildly bearish, suggesting mixed signals across different time frames. The daily moving averages also reflect a mildly bearish position. The Bollinger Bands show a bullish trend on the monthly chart, while the weekly chart remains sideways. Overall, the indicators suggest a mildly bearish sentiment, primarily driven by the daily moving averages and the monthly MACD. There is no available return data to compare the company's performance against the S&P 500....
Read MoreIs Catalyst Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-27 11:52:22As of 24 October 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD indicates a mildly bearish stance. The daily moving averages are also mildly bearish, which supports the overall bearish sentiment. The Bollinger Bands show a bullish signal on the monthly timeframe, but the weekly timeframe remains sideways. KST and Dow Theory both present a mildly bullish signal on the weekly but are mildly bearish on the monthly. The RSI shows no signal in both timeframes, indicating a lack of momentum. Overall, the indicators suggest a mildly bearish technical stance, with mixed signals across different timeframes. Multi-period return data is not available for comparison with the S&P 500....
Read MoreIs Catalyst Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-26 11:26:55As of 24 October 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals across time frames. The daily moving averages are also mildly bearish, reinforcing the current trend. The company has shown a 2.00% return over the past week, outperforming the S&P 500's 1.92%, but has underperformed over longer periods, with a YTD return of 0.43% compared to the S&P 500's 15.47%. Overall, the technical stance is mildly bearish, driven primarily by the daily moving averages and monthly MACD....
Read More
Catalyst Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-10-07 19:29:54Catalyst Pharmaceuticals, Inc. has experienced recent stock fluctuations, currently priced at $20.73. The company has shown volatility over the past year, with a trading range between $19.05 and $26.58. Despite mixed technical indicators, Catalyst has outperformed the S&P 500 in the short term, while its long-term returns remain notable.
Read MoreIs Catalyst Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-07 12:16:32As of 3 October 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from bearish to mildly bearish. The weekly MACD and KST indicators are bearish, while the monthly MACD and KST are mildly bearish. The daily moving averages also indicate a mildly bearish stance. Bollinger Bands show a mixed signal with a bearish weekly and bullish monthly. The Dow Theory indicates a mildly bearish trend on the monthly timeframe. In terms of performance, the stock has outperformed the S&P 500 over the past week with a return of 6.04% compared to 1.09%, but has underperformed over the longer periods, with a year-to-date return of -0.67% versus 14.18% for the S&P 500. Overall, the current technical stance is mildly bearish....
Read MoreIs Catalyst Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-06 12:06:36As of 3 October 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD and KST indicators both showing bearish signals, while the daily moving averages also reflect a mildly bearish outlook. The Bollinger Bands present a mixed picture with a mildly bearish stance on the weekly and a bullish stance on the monthly. Dow Theory indicates a mildly bullish trend on the weekly but mildly bearish on the monthly. In terms of performance, Catalyst Pharmaceuticals has outperformed the S&P 500 over the past week and month, with returns of 6.76% and 5.31% respectively, but it lags behind the benchmark on a year-to-date and one-year basis. Overall, the technical indicators suggest caution despite some short-term strength....
Read MoreIs Catalyst Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-05 11:51:35As of 3 October 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from bearish to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bearish. The daily moving averages also indicate a mildly bearish stance. Bollinger Bands show a mixed signal with a mildly bearish weekly outlook and a bullish monthly perspective. The KST is bearish on a weekly basis and mildly bearish monthly, while the Dow Theory presents a mildly bullish weekly view but a mildly bearish monthly stance. In terms of performance, Catalyst Pharmaceuticals has outperformed the S&P 500 over the past week and month, returning 6.76% and 5.31% respectively, while the S&P 500 returned 1.09% and 4.15%. However, year-to-date and one-year returns are negative compared to the S&P 500, with Catalyst at -0.14% and 4.83% versus the S&P's 14.18% and 17.82%. Over the longer term, Catalyst has significantly ...
Read More
Catalyst Pharmaceuticals Hits 52-Week Low at $19.05 Amid Market Volatility
2025-09-26 15:07:02Catalyst Pharmaceuticals, Inc. has reached a new 52-week low of USD 19.05, reflecting a decline for the small-cap company in the Pharmaceuticals & Biotechnology sector. Despite this, it has achieved a one-year performance of 22.39%, outperforming the S&P 500, and maintains a market capitalization of USD 2,458 million.
Read MoreIs Catalyst Pharmaceuticals, Inc. technically bullish or bearish?
2025-09-20 19:48:42As of 7 August 2025, the technical trend for Catalyst Pharmaceuticals, Inc. has changed from mildly bullish to bearish. The weekly MACD is bearish, and the daily moving averages also indicate a bearish stance. The KST is bearish on the weekly and mildly bearish on the monthly. The Bollinger Bands show a mildly bearish signal on the weekly and mildly bullish on the monthly, while the OBV is mildly bearish across both time frames. The RSI shows no signal on both weekly and monthly charts. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -2.25% compared to the S&P 500's 12.22%, and a one-year return of -0.15% versus 17.14%. Overall, the current technical stance is bearish, indicating weakness in the stock's performance....
Read More





